T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations

Abstract Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nucleic acids research 2022-01, Vol.50 (D1), p.D883-D887
Hauptverfasser: Nersisyan, Stepan, Zhiyanov, Anton, Shkurnikov, Maxim, Tonevitsky, Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page D887
container_issue D1
container_start_page D883
container_title Nucleic acids research
container_volume 50
creator Nersisyan, Stepan
Zhiyanov, Anton
Shkurnikov, Maxim
Tonevitsky, Alexander
description Abstract Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity.
doi_str_mv 10.1093/nar/gkab701
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8385993</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/nar/gkab701</oup_id><sourcerecordid>2561926120</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVpaTZpT70XnUohuNGXvVYOhWXJR2Gh0KQ99CJG8ihxYluOJAfy7-tktyG99DSHeXjeYV5CPnD2hTMtjwaIR1e3YJeMvyILLitRKF2J12TBJCsLzlS9R_ZTumGMK16qt2RPKqkrqfmC_L4s1uHXMQXqQj9GvMYhtfdIxxAzdDR4er5ZFSOOuW2QtkPGCC63YUgUvEeXsaH2gV6sflw8igpB-ynDE_COvPHQJXy_mwfk5-nJ5fq82Hw_-7ZebQqnuMhFbS0HsLUsEbDkGmTlVOWaZeMVt6qUsNRKcr9sagE1Olta8LbxEoUDjVwekK9b7zjZHhuHQ47QmTG2PcQHE6A1_26G9tpchXtTy7rUWs6CzztBDHcTpmz6NjnsOhgwTMmIsuJaVFywGT3coi6GlCL65xjOzGMbZm7D7NqY6Y8vL3tm_75_Bj5tgTCN_zX9AeuxlXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561926120</pqid></control><display><type>article</type><title>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Nersisyan, Stepan ; Zhiyanov, Anton ; Shkurnikov, Maxim ; Tonevitsky, Alexander</creator><creatorcontrib>Nersisyan, Stepan ; Zhiyanov, Anton ; Shkurnikov, Maxim ; Tonevitsky, Alexander</creatorcontrib><description>Abstract Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity.</description><identifier>ISSN: 0305-1048</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/gkab701</identifier><identifier>PMID: 34396391</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Alleles ; Codon, Terminator ; COVID-19 - immunology ; COVID-19 - virology ; Database Issue ; Databases, Factual ; Epitopes, T-Lymphocyte - immunology ; HLA Antigens - genetics ; HLA Antigens - immunology ; HLA Antigens - metabolism ; HLA-B7 Antigen - immunology ; Host-Pathogen Interactions ; Humans ; India ; Mutation ; SARS-CoV-2 - genetics ; SARS-CoV-2 - pathogenicity ; United Kingdom ; Viral Proteins - genetics ; Viral Proteins - immunology</subject><ispartof>Nucleic acids research, 2022-01, Vol.50 (D1), p.D883-D887</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. 2022</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</citedby><cites>FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</cites><orcidid>0000-0002-8830-4679</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385993/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385993/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1604,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34396391$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nersisyan, Stepan</creatorcontrib><creatorcontrib>Zhiyanov, Anton</creatorcontrib><creatorcontrib>Shkurnikov, Maxim</creatorcontrib><creatorcontrib>Tonevitsky, Alexander</creatorcontrib><title>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</title><title>Nucleic acids research</title><addtitle>Nucleic Acids Res</addtitle><description>Abstract Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity.</description><subject>Alleles</subject><subject>Codon, Terminator</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - virology</subject><subject>Database Issue</subject><subject>Databases, Factual</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>HLA Antigens - genetics</subject><subject>HLA Antigens - immunology</subject><subject>HLA Antigens - metabolism</subject><subject>HLA-B7 Antigen - immunology</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>India</subject><subject>Mutation</subject><subject>SARS-CoV-2 - genetics</subject><subject>SARS-CoV-2 - pathogenicity</subject><subject>United Kingdom</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - immunology</subject><issn>0305-1048</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVpaTZpT70XnUohuNGXvVYOhWXJR2Gh0KQ99CJG8ihxYluOJAfy7-tktyG99DSHeXjeYV5CPnD2hTMtjwaIR1e3YJeMvyILLitRKF2J12TBJCsLzlS9R_ZTumGMK16qt2RPKqkrqfmC_L4s1uHXMQXqQj9GvMYhtfdIxxAzdDR4er5ZFSOOuW2QtkPGCC63YUgUvEeXsaH2gV6sflw8igpB-ynDE_COvPHQJXy_mwfk5-nJ5fq82Hw_-7ZebQqnuMhFbS0HsLUsEbDkGmTlVOWaZeMVt6qUsNRKcr9sagE1Olta8LbxEoUDjVwekK9b7zjZHhuHQ47QmTG2PcQHE6A1_26G9tpchXtTy7rUWs6CzztBDHcTpmz6NjnsOhgwTMmIsuJaVFywGT3coi6GlCL65xjOzGMbZm7D7NqY6Y8vL3tm_75_Bj5tgTCN_zX9AeuxlXU</recordid><startdate>20220107</startdate><enddate>20220107</enddate><creator>Nersisyan, Stepan</creator><creator>Zhiyanov, Anton</creator><creator>Shkurnikov, Maxim</creator><creator>Tonevitsky, Alexander</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8830-4679</orcidid></search><sort><creationdate>20220107</creationdate><title>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</title><author>Nersisyan, Stepan ; Zhiyanov, Anton ; Shkurnikov, Maxim ; Tonevitsky, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-8bb1aab835eae519a36c46cd7df41b453a79431f7d82a8ecb5bafbdf3e2ca9e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alleles</topic><topic>Codon, Terminator</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - virology</topic><topic>Database Issue</topic><topic>Databases, Factual</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>HLA Antigens - genetics</topic><topic>HLA Antigens - immunology</topic><topic>HLA Antigens - metabolism</topic><topic>HLA-B7 Antigen - immunology</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>India</topic><topic>Mutation</topic><topic>SARS-CoV-2 - genetics</topic><topic>SARS-CoV-2 - pathogenicity</topic><topic>United Kingdom</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nersisyan, Stepan</creatorcontrib><creatorcontrib>Zhiyanov, Anton</creatorcontrib><creatorcontrib>Shkurnikov, Maxim</creatorcontrib><creatorcontrib>Tonevitsky, Alexander</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nersisyan, Stepan</au><au>Zhiyanov, Anton</au><au>Shkurnikov, Maxim</au><au>Tonevitsky, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucleic Acids Res</addtitle><date>2022-01-07</date><risdate>2022</risdate><volume>50</volume><issue>D1</issue><spage>D883</spage><epage>D887</epage><pages>D883-D887</pages><issn>0305-1048</issn><eissn>1362-4962</eissn><abstract>Abstract Rapidly appearing SARS-CoV-2 mutations can affect T cell epitopes, which can help the virus to evade either CD8 or CD4 T-cell responses. We developed T-cell COVID-19 Atlas (T-CoV, https://t-cov.hse.ru) – the comprehensive web portal, which allows one to analyze how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The data are presented for common virus variants and the most frequent HLA class I and class II alleles. Binding affinities of HLA molecules and viral peptides were assessed with accurate in silico methods. The obtained results highlight the importance of taking HLA alleles diversity into account: mutation-mediated alterations in HLA-peptide interactions were highly dependent on HLA alleles. For example, we found that the essential number of peptides tightly bound to HLA-B*07:02 in the reference Wuhan variant ceased to be tight binders for the Indian (Delta) and the UK (Alpha) variants. In summary, we believe that T-CoV will help researchers and clinicians to predict the susceptibility of individuals with different HLA genotypes to infection with variants of SARS-CoV-2 and/or forecast its severity.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34396391</pmid><doi>10.1093/nar/gkab701</doi><orcidid>https://orcid.org/0000-0002-8830-4679</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-1048
ispartof Nucleic acids research, 2022-01, Vol.50 (D1), p.D883-D887
issn 0305-1048
1362-4962
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8385993
source MEDLINE; DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; PubMed Central; Free Full-Text Journals in Chemistry
subjects Alleles
Codon, Terminator
COVID-19 - immunology
COVID-19 - virology
Database Issue
Databases, Factual
Epitopes, T-Lymphocyte - immunology
HLA Antigens - genetics
HLA Antigens - immunology
HLA Antigens - metabolism
HLA-B7 Antigen - immunology
Host-Pathogen Interactions
Humans
India
Mutation
SARS-CoV-2 - genetics
SARS-CoV-2 - pathogenicity
United Kingdom
Viral Proteins - genetics
Viral Proteins - immunology
title T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T18%3A26%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T-CoV:%20a%20comprehensive%20portal%20of%20HLA-peptide%20interactions%20affected%20by%20SARS-CoV-2%20mutations&rft.jtitle=Nucleic%20acids%20research&rft.au=Nersisyan,%20Stepan&rft.date=2022-01-07&rft.volume=50&rft.issue=D1&rft.spage=D883&rft.epage=D887&rft.pages=D883-D887&rft.issn=0305-1048&rft.eissn=1362-4962&rft_id=info:doi/10.1093/nar/gkab701&rft_dat=%3Cproquest_pubme%3E2561926120%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2561926120&rft_id=info:pmid/34396391&rft_oup_id=10.1093/nar/gkab701&rfr_iscdi=true